Search results for "Vascular Grafting"

showing 6 items of 6 documents

Value of the deep femoral artery as alternative inflow source in infrainguinal bypass surgery.

2013

Background The purpose of this study was to analyze the long-term results of infrainguinal bypass surgery using the deep femoral artery (DFA) as the inflow source. Methods Between 1998 and 2011, 88 bypasses of the lower limb were placed in 86 patients (mean age 71 years) using the deep femoral artery as inflow. Patients' records were retrieved from a computerized database and analyzed retrospectively. Results Critical limb ischemia (rest pain/tissue loss) was the indication in the majority (87.5%) of cases. The distal anastomosis of the bypass grafts was located at the popliteal level in 32 cases and the tibial (pedal) level in 52 cases, respectively, with the autologous vein as conduit in …

Malemedicine.medical_specialtyTime FactorsInfrainguinal bypassCritical IllnessInflowFemoral arteryKaplan-Meier EstimateIschemiamedicine.arterymedicineDeep Femoral ArteryHumansVascular PatencyAgedRetrospective StudiesAged 80 and overPeripheral Vascular DiseasesGroinbusiness.industryGeneral MedicineCritical limb ischemiaPerioperativeMiddle Agedmedicine.diseaseLimb SalvageSurgeryFemoral Arterymedicine.anatomical_structureTreatment OutcomeLower ExtremitySurgeryVascular GraftingRadiologymedicine.symptomCardiology and Cardiovascular MedicinebusinessCalcificationAnnals of vascular surgery
researchProduct

External polytetrafluoroethylene reinforcement of varicose autologous vein grafts in peripheral bypass surgery produces durable bypass function

2017

Abstract Objective Use of autologous veins as peripheral bypass graft may become critical in the presence of significant varicose degeneration of the harvested vein. External support of such dilated veins with standard polytetrafluoroethylene (PTFE) prostheses was recommended as an option to use these veins for peripheral bypass. A single-center experience with this technique regarding long-term graft function, secondary reinterventions, and potential graft degeneration is presented. Methods Between January 1995 and January 2006, there were 54 patients with varicose veins who underwent 57 consecutive infrainguinal vein bypass operations with PTFE reinforcement in 57 limbs. Indications for s…

Malemedicine.medical_specialtyTime Factors030204 cardiovascular system & hematology030230 surgeryTransplantation AutologousVaricose VeinsPopliteal aneurysm03 medical and health sciences0302 clinical medicineGermanyVaricose veinsmedicineHumansSaphenous VeinVeinPolytetrafluoroethyleneAgedRetrospective StudiesAged 80 and overUltrasonography Doppler Duplexmedicine.diagnostic_testbusiness.industryIncidenceGraft SurvivalAngiographyGraft Occlusion VascularMiddle Agedmedicine.diseaseSurgerySurvival RateTransplantationStenosismedicine.anatomical_structureBypass surgeryAngiographyFemaleVascular GraftingSurgerymedicine.symptomCardiology and Cardiovascular MedicinebusinessClaudicationFollow-Up StudiesJournal of Vascular Surgery
researchProduct

Mid- and Longer-term Follow up of Chimney and/or Periscope Grafts and Risk Factors for Failure

2016

Objective The aim was to report on chimney and periscope grafts (CPGs) and their mid- and longer-term outcomes when they are used to preserve reno-visceral artery (RVA) perfusion in endovascular repair of pararenal (PRAAs) or thoraco-abdominal aortic aneurysm (TAAAs). In addition, factors associated with CPG failure are presented. Limited data exist on the outcomes of CPGs, and mid- and long-term results are generally not reported. Methods This was a prospective study in a cohort of 100 patients with PRAA (69) or TAAA (31). A total of 224 (mean 2.24 per patient) RVAs were preserved with 136 (61%) chimney and 88 (39%) periscope grafts. CPGs were constructed mainly using self expandable stent…

MalePercutaneousmedicine.medical_treatment030204 cardiovascular system & hematologyEndovascular aneurysm repairSettore MED/22 - Chirurgia VascolareAortic aneurysm0302 clinical medicineRenal ArteryRisk FactorsOcclusion030212 general & internal medicineTreatment FailureProspective cohort studyAortaPararenal aortic aneurysm10042 Clinic for Diagnostic and Interventional RadiologyReno2746 SurgeryAortic AneurysmFemaleRadiologyCardiology and Cardiovascular Medicinemedicine.medical_specialty610 Medicine & health2705 Cardiology and Cardiovascular Medicine03 medical and health sciencesEndovascular aneurysm repairabdominal aortic aneurysmAneurysmChimney and periscope graftChimney and periscope graft; Complex aortic aneurysm; Endovascular aneurysm repair; Pararenal aortic aneurysm; Reno-visceral arteries; Thoraco-abdominal aortic aneurysm; Cardiology and Cardiovascular Medicine; SurgerymedicineHumansAgedRetrospective StudiesReno-visceral arterieThoraco-abdominal aortic aneurysmbusiness.industryComplex aortic aneurysmStentRetrospective cohort studyThoracomedicine.diseaseSurgeryvisceral arteriesSurgeryVascular GraftingbusinessFollow-Up Studies
researchProduct

Modular Small Diameter Vascular Grafts with Bioactive Functionalities.

2015

We report the fabrication of a novel type of artificial small diameter blood vessels, termed biomimetic tissue-engineered blood vessels (bTEBV), with a modular composition. They are composed of a hydrogel scaffold consisting of two negatively charged natural polymers, alginate and a modified chitosan, N,O-carboxymethyl chitosan (N,O-CMC). Into this biologically inert scaffold two biofunctionally active biopolymers are embedded, inorganic polyphosphate (polyP) and silica, as well as gelatin which exposes the cell recognition signal, Arg-Gly-Asp (RGD). These materials can be hardened by exposure to Ca(2+) through formation of Ca(2+) bridges between the polyanions, alginate, N,O-CMC, and polyP…

food.ingredientAlginateslcsh:MedicineBiocompatible Materialsmacromolecular substancesengineering.materialGelatinChitosanchemistry.chemical_compoundCalcium ChloridefoodTissue engineeringGlucuronic AcidBlood vessel prosthesisPolyphosphatesElastic ModulusTensile StrengthAbsorbable ImplantsMaterials TestingHuman Umbilical Vein Endothelial CellsHumanslcsh:ScienceBlood CoagulationCell Line Transformedchemistry.chemical_classificationChitosanMultidisciplinaryTissue EngineeringTissue ScaffoldsHexuronic Acidslcsh:Rtechnology industry and agricultureBiomaterialEndothelial CellsHydrogelsPolymerSilicon DioxideBlood Vessel ProsthesischemistrySelf-healing hydrogelsengineeringlcsh:QVascular GraftingBiopolymerOligopeptidesBiomedical engineeringResearch ArticlePloS one
researchProduct

Mortality rates and risk factors for emergent open repair of abdominal aortic aneurysms in the endovascular era

2018

The background of this paper is to report the mortality at 30 and 90 days and at mean follow-up after open abdominal aortic aneurysms (AAA) emergent repair and to identify predictive risk factors for 30- and 90-day mortality. Between 1997 and 2002, 104 patients underwent emergent AAA open surgery. Symptomatic and ruptured AAAs were observed, respectively, in 21 and 79% of cases. Mean patient age was 70 (SD 9.2) years. Mean aneurysm maximal diameter was 7.4 (SD 1.6) cm. Primary endpoints were 30- and 90-day mortality. Significant mortality-related risk factor identification was the secondary endpoint. Open repair trend and its related perioperative mortality with a per-year analysis and a co…

Malemedicine.medical_specialtyAbdominal compartment syndromemedicine.medical_treatment610 Medicine & healthSymptomatic030204 cardiovascular system & hematologySettore MED/22 - Chirurgia VascolareEndovascular aneurysm repairEndovascular aneurysm repair03 medical and health sciences0302 clinical medicineAneurysmRisk FactorsmedicineHumansMortalityRisk factorAgedRetrospective Studiesbusiness.industryOpen repairMortality rateEndovascular Procedures10060 Epidemiology Biostatistics and Prevention Institute (EBPI)PerioperativeMiddle Agedmedicine.diseaseSurvival AnalysisRupturedAbdominal aortic aneurysm10020 Clinic for Cardiac Surgery2746 SurgerySurgeryTreatment Outcome030220 oncology & carcinogenesisAbdominal aortic aneurysmFemaleVascular GraftingSurgeryEmergenciesbusinessAortic Aneurysm AbdominalFollow-Up StudiesAbdominal surgeryUpdates in Surgery
researchProduct

How should I treat a DeBakey type I acute aortic dissection four weeks after transcatheter aortic valve implantation in an old, fragile patient?

2015

Aged 80 and overAortic dissectionmedicine.medical_specialtyCardiopulmonary BypassTranscatheter aorticbusiness.industryFrail ElderlyEndovascular ProceduresAortic Valve Stenosismedicine.diseaseAortic AneurysmTranscatheter Aortic Valve ReplacementAortic DissectionPostoperative ComplicationsAcute DiseasemedicineHumansFemaleVascular GraftingRadiologyCardiology and Cardiovascular MedicinebusinessAortaEuroIntervention
researchProduct